Silver dressings could simplify infection care for dialysis patients
NCT ID NCT07641491
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This pilot study tests whether silver-impregnated dressings can effectively manage catheter exit-site or tunnel infections in adults on peritoneal dialysis. Sixty participants will be randomly assigned to receive either the silver dressing or standard daily antibiotic dressings, alongside systemic antibiotics. The study aims to see if the silver dressing is feasible, acceptable, and reduces the frequency of dressing changes. Results will guide future larger trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- silver-impregnated dressing
- What this could lead to
- If successful, this could offer a simpler, less frequent dressing option for managing catheter infections in dialysis patients, potentially reducing treatment burden.
- What could go wrong
- This is a small pilot study with only 60 participants, so results may not apply broadly. The dressing may not work as well as standard antibiotics, and some patients may have allergic reactions to silver.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL DIALYSIS CATHETER EXIT SITE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Singapore General Hospital
Singapore, 169608, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.